ThinkSabio

$URGN

$35.17▲ +2.1% YTD

6 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
URGN ▲ +2.1% - UroGen Pharma Ltd.
CP $35.17▲ +2.1%Nov 3, 2026 · ThinkSabio Blog

$URGN - UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference…

News
URGN ▲ +1.2% - UroGen Pharma Ltd.
CP $34.35▲ +1.2%Oct 28, 2026 · ThinkSabio Blog

$URGN - UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract…

SEC 13D/G
URGN - UroGen Pharma Ltd. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified
$33.91▲ 49.38%Oct 27, 2026 · ThinkSabio Blog

$URGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #URGN UroGen Pharma Ltd. : $33.91 Sector: Healthcare | YTD: 🔼+ 4…

News
URGN ▼ -0.4% - UroGen Pharma Ltd.
CP $33.91▲ -0.4%Oct 27, 2026 · ThinkSabio Blog

$URGN - UroGen Pharma to Report Third Quarter 2026 Financial Results on Wednesday, November 4th, 2026…

News
URGN ▼ -0.6% - UroGen Pharma Ltd.
CP $43.15▲ -0.6%Sep 2, 2026 · ThinkSabio Blog

$URGN - UroGen Pharma to Present at Upcoming Investor Conferences…

SEC 13D/G
URGN - UroGen Pharma Ltd. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified
$49.00▲ 115.86%Aug 12, 2026 · ThinkSabio Blog

$URGN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #URGN UroGen Pharma Ltd. : $49.00 Sector: Healthcare | YTD: 🔼+ 1…